相关实验视频

Updated: Jul 8, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

对于患有急性淋巴细胞白血病的肥胖患者的阿斯帕拉金纳斯剂量以及对结果有影响的因素

Ryan D Cassaday¹

¹Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Best practice & research. Clinical haematology

|December 13, 2023

概括

肥胖症使急性淋巴细胞白血病 (ALL) 治疗复杂化,尤其是成年人. 本综述综合了这些发现,并提出了对肥胖成年人更安全,更有效的ALL管理的建议.

科学领域:

在瘤学瘤学.
血液学血液学血液学
临床药理学临床药理学

背景情况:

阿斯巴拉金酶是儿科急性淋巴细胞白血病 (ALL) 治疗的基石.
由于毒性,其在成人ALL的使用是有限的,肥胖症成为一个显著的复杂因素.

研究的目的:

审查最近关于肥胖对急性淋巴细胞白血病 (ALL) 的阿斯巴拉基纳斯治疗影响的研究结果.
为管理肥胖成人ALL患者的阿斯巴拉金酶治疗方案提供临床建议.
确定未来的研究方向,以优化这一群体的治疗.

主要方法:

对大型前性研究的后期分析进行了审查.
综合了关于阿斯巴拉基纳斯毒性和肥胖症的儿童和成人文献.
综合了临床数据,制定了建议.

主要成果:

肥胖是影响ASPARAGINASE的治疗挑战和ALL患者中毒性的关键因素.
证据强调了儿科与成年人群的不同影响和管理考虑因素.
最近的分析强调了需要量身定制的治疗方法.

结论:

肥胖严重影响阿斯巴拉基纳斯治疗成年ALL的有效性和安全性.
建议修改治疗策略,以减轻与肥胖有关的并发症.
进一步的研究至关重要,以改善接受asparaginase的ALL肥胖成年人的结果.

关键词:

急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.亚斯巴拉奇纳酶是一种埃尔维尼亚埃尔维尼亚肥胖问题肥胖问题佩加斯帕尔加斯气体

更多相关视频

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...